Production (Stage)
PharmaRoth Labs, Inc.
ROTH
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Revenue | 200.20K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 200.20K | -- | -- | -- | -- |
| Cost of Revenue | 119.70K | -- | -- | -- | -- |
| Gross Profit | 80.50K | -- | -- | -- | -- |
| SG&A Expenses | 178.70K | 48.40K | 223.20K | 4.50K | 1.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 298.40K | 48.40K | 223.20K | 4.50K | 1.00K |
| Operating Income | -98.20K | -48.40K | -223.20K | -4.50K | -1.00K |
| Income Before Tax | -100.80K | -54.20K | -223.20K | -254.50K | -1.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -100.80K | -54.20K | -223.20K | -254.50K | -1.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -100.80K | -54.20K | -223.20K | -254.50K | -1.00K |
| EBIT | -98.20K | -48.40K | -223.20K | -4.50K | -1.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 137.77M | 127.50M | 127.97M | 127.50M | 127.50M |
| Average Diluted Shares Outstanding | 137.77M | 127.50M | 127.97M | 127.50M | 127.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |